ライフサイエンスコーパス: primary graft dysfunction

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 olonged ventilation, renal insufficiency and primary graft dysfunction.

2 risk is directly related to the severity of primary graft dysfunction.

3 mong subjects who died by 30 days, 43.6% had primary graft dysfunction.

4 ts at our program and graded the severity of primary graft dysfunction according to the International

5 emia-reperfusion injury is the main cause of primary graft dysfunction after lung transplantation and

6 reperfusion injury is a major determinant of primary graft dysfunction after lung transplantation, an

7 y be a novel therapeutic strategy to prevent primary graft dysfunction after lung transplantation.

8 However, there was no association between primary graft dysfunction and acute rejection or lymphoc

9 etion may help to predict the development of primary graft dysfunction and avoid the need for retrans

10 ence of major complications including severe primary graft dysfunction and early mortality rates were

11 d a significantly higher incidence of severe primary graft dysfunction and higher short- and long-ter

12 Postoperatively, the incidence of severe primary graft dysfunction and the incidence of acute ren

13 Primary graft dysfunction contributes to nearly half of

14 Among the 334 recipients, 65 did not have primary graft dysfunction (grade 0), 130 had grade 1, 69

15 nts surviving at least 1 year, those who had primary graft dysfunction had significantly worse surviv

16 Survivors of primary graft dysfunction have increased risk of death e

17 Long-term outcomes of subjects with primary graft dysfunction have not been studied.

18 the lung for ischemia reperfusion injury and primary graft dysfunction in the recipient.

19 ed use of cardiopulmonary bypass, and severe primary graft dysfunction increased the risk for death i

20 Primary graft dysfunction is a common complication after

21 Primary graft dysfunction is a severe acute lung injury

22 Primary graft dysfunction is associated with an increase

23 which are now discarded because the risk of primary graft dysfunction is considered too great.

24 We evaluated the impact of primary graft dysfunction on acute rejection, lymphocyti

25 We examined the impact of primary graft dysfunction on bronchiolitis obliterans sy

26 evels are associated with the development of primary graft dysfunction (PGD) after lung transplantati

27 1) levels in plasma would be associated with primary graft dysfunction (PGD) after lung transplantati

28 Primary graft dysfunction (PGD) is a major complication

29 Primary graft dysfunction (PGD) is a significant cause o

30 Primary graft dysfunction (PGD) is a significant contrib

31 Primary graft dysfunction (PGD) is the main cause of ear

32 Primary graft dysfunction (PGD) is the most important ca

33 Twenty-three patients with Grade 3 primary graft dysfunction (PGD) were frequency matched w

34 l allografts may be at an increased risk for primary graft dysfunction (PGD), the leading cause of ea

35 demographics may influence the incidence of primary graft dysfunction (PGD).

36 antation with good early outcome [absence of primary graft dysfunction- (PGD) grade 3]; (II) PGD3: bi

37 intensive care unit stay (P = 0.74), highest primary graft dysfunction score (P = 0.67) and hospital

38 e care unit stay, hospital stay, and highest primary graft dysfunction score within 72 hours) and lon

39 Wisconsin solution in grafts with subsequent primary graft dysfunction, suggesting a slower recovery

40 All-cause mortality at 30 days was 42.1% for primary graft dysfunction versus 6.1% in patients withou

41 The overall incidence of primary graft dysfunction was 10.2% (95% confidence inte

42 hiolitis obliterans syndrome associated with primary graft dysfunction was independent of acute rejec

43 In multivariable regression analysis, primary graft dysfunction was the predominant perioperat

44 In the univariable analysis, all grades of primary graft dysfunction were associated with a signifi

45 We sought to test the relationship of primary graft dysfunction with both short- and long-term

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。